The vaccines are also easier to make and multivalent shots can be formulated in prefilled syringes, said Vicebio chief executive Emmanuel Hanon, who was formerly GSK's vaccine chief. New Cambridge ...

GSK on Wednesday said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, citing AI-driven cost cuts ...

Uncertainty continues to hang over the latest round of financial results and forecasts for companies both big and small as ...

U.S.-listed shares of GSK are gaining in intraday trading Wednesday after the British pharma giant posted ...

GSK (GSK) said it is “pleased” that the Advisory Committee on Immunization Practices voted in favor of recommending the use of RSV vaccines including GSK’s AREXVY in adults aged 50-59 who ...

GSK (GSK) plc announced the authorization of Blenrep by the Medicines and Healthcare products Regulatory Agency. “In the UK, Blenrep is approved for the treatment of adults with multiple myeloma ...

April 3 (Reuters) - British pharmaceutical giant GlaxoSmithKline (GSK.L), opens new tab and rival Pfizer (PFE.N), opens new tab have agreed to end a lawsuit that alleged Pfizer's respiratory ...

Q1 2025 Earnings Conference Call April 30, 2025 7:00 AM ETCompany ParticipantsConstantin Fest - Head of IREmma Walmsley - CEOLuke Miels ...

Going forward, PTS and Appspace are providing ongoing service and support, with a team ensuring the systems perform at peak ...

Abnormal kinase signaling can promote other harmful traits, such as neuroinflammation and neuronal cell death. On the other ...

Hence, she liquidated all but a tiny percentage of her GSK holding, dramatically boosting her net gains. Today, we both own small legacy stakes in GSK, but nothing like the lump we once had.